Showing results (1781-1790 of 2,455) with videos related to

Sort By:
Pageof 246
Oncology Reports|October 16, 2018
Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferationJingling Jin, Junliang Jin, Sarah E Woodfield, et al.
Journal of Virology|June 10, 2016
Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus InfectionVanessa M Cowton, Allan G N Angus, Sarah J Cole, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2016
17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycleAndrea Magri, Matteo N Barbaglia, Chiara Z Foglia, et al.
Molecular Nutrition & Food Research|April 30, 2013
Epicatechin regulation of mitochondrial structure and function is opioid receptor dependentMathivadhani Panneerselvam, Sameh S Ali, J Cameron Finley, et al.
Journal of Virology|February 26, 2016
Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV InfectionRachael E Swann, Vanessa M Cowton, Mark W Robinson, et al.
The Journal of General Virology|February 15, 2008
Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoproteinAnia M Owsianka, Alexander W Tarr, Zhen-Yong Keck, et al.
Journal of Virology|September 21, 2012
Toward a hepatitis C virus vaccine: the structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibodyJane A Potter, Ania M Owsianka, Nathan Jeffery, et al.
Pageof 246